Stay updated with breaking news from Sheet Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Growing physician awareness and usage of VONJO® (pacritinib) drove quarterly double-digit revenue growth – – VONJO® net product revenue exceeded year-end...
- Growing physician awareness and usage of VONJO® (pacritinib) drove quarterly double-digit revenue growth - - VONJO® net product revenue exceeded year-end goal with a total of $54 million for 2022 and
BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the
21.02.2023 - Fourth Quarter Highlights -Diluted Earnings Per Share of $1.98, Up 49% Year-Over-Year--New Home Deliveries of 2,016 for Home Sales Revenue of $1.5 Billion--Homebuilding Gross Margin Percentage of 25.0%--Pre-tax Margin of 18.0%--Return on Average ...
Please note that the limited information that follows in this press release is a summary and is not adequate for making an informed investment decision.MCLEAN, VA / ACCESSWIRE / February 21, 2023 / Gladstone